These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2799767)

  • 1. Importance for blood anticoagulant activity of a 2-sulfate group on L-iduronic acid residues in heparin.
    Rej R; Jaseja M; Perlin AS
    Thromb Haemost; 1989 Jun; 61(3):540. PubMed ID: 2799767
    [No Abstract]   [Full Text] [Related]  

  • 2. An investigation of the functional role of the carboxylic groups of heparin. Affinity for antithrombin III and anti-Xa activity of selectively carboxyl esterified heparin.
    Mardiguian J; Trillou M
    Semin Thromb Hemost; 1985 Jan; 11(1):34-6. PubMed ID: 3975640
    [No Abstract]   [Full Text] [Related]  

  • 3. The distribution of sulfated uronic acid and hexosamine residues in heparin and heparan sulfate.
    Cifonelli JA; King J
    Connect Tissue Res; 1975; 3(1):97-104. PubMed ID: 126132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha-L-iduronate conformation on the molecular shape of heparin.
    Atkins ED; Nieduszynski IA
    Fed Proc; 1977 Jan; 36(1):78-83. PubMed ID: 830560
    [No Abstract]   [Full Text] [Related]  

  • 5. The uronic acid composition of anticoagulantly active and inactive heparin.
    Rosenfeld L; Radoff S; Danishefsky I
    Arch Biochem Biophys; 1985 Nov; 242(2):574-8. PubMed ID: 4062296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
    Calabrese GC; Alberto MF; Tubio R; Marani MM; Fernández De Recondo ME; Lazzari M; Recondo EF
    Thromb Res; 2004; 113(3-4):243-50. PubMed ID: 15140589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of ester sulfates in heparin to solvolysis and dilute acid treatment.
    Kosakai M; Yosizawa Z
    J Biochem; 1979 Jul; 86(1):147-53. PubMed ID: 573262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural modification induced in heparin by a Fenton-type depolymerization process.
    Vismara E; Pierini M; Guglieri S; Liverani L; Mascellani G; Torri G
    Semin Thromb Hemost; 2007 Jul; 33(5):466-77. PubMed ID: 17629843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
    Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
    J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
    Hallak LK; Collins PL; Knudson W; Peeples ME
    Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical change involved in the oxidative-reductive depolymerization of heparin.
    Nagasawa K; Uchiyama H; Sato N; Hatano A
    Carbohydr Res; 1992 Dec; 236():165-80. PubMed ID: 1337863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in the carbazole assay for N-desulfonated/N-acylated heparin derivatives.
    Hattan CM; Kerns RJ
    Carbohydr Res; 2007 Dec; 342(17):2664-9. PubMed ID: 17850773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function relationships of heparin species.
    Rosenberg RD; Armand G; Lam L
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3065-9. PubMed ID: 277908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR spectroscopy of heparin.
    Perlin AS
    Fed Proc; 1977 Jan; 36(1):106-9. PubMed ID: 830551
    [No Abstract]   [Full Text] [Related]  

  • 15. An efficient synthesis of L-idose and L-iduronic acid thioglycosides and their use for the synthesis of heparin oligosaccharides.
    Tatai J; Osztrovszky G; Kajtár-Peredy M; Fügedi P
    Carbohydr Res; 2008 Mar; 343(4):596-606. PubMed ID: 18237719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo disposition.
    Bjornsson TD; Schneider DE; Hecht AR
    J Pharmacol Exp Ther; 1988 Jun; 245(3):804-8. PubMed ID: 3164387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
    Halldórsdóttir AM; Zhang L; Tollefsen DM
    Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of chemical of heparin to its anticoagulant activity.
    Cifonelli JA
    Adv Exp Med Biol; 1975; 52():95-103. PubMed ID: 1124709
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.
    Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A
    Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate C5-epimerase is essential for heparin biosynthesis in mast cells.
    Feyerabend TB; Li JP; Lindahl U; Rodewald HR
    Nat Chem Biol; 2006 Apr; 2(4):195-6. PubMed ID: 16532012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.